|
1 Indications And Usage Abraxane Is A Microtubule Inhibitor Indicated For The Treatment Of: Metastatic Breast Cancer, After Failure Of Combination Chemotherapy For Metastatic Disease Or Relapse Within 6 Months Of Adjuvant Chemotherapy. Prior Therapy Should Have Included An Anthracycline Unless Clinically Contraindicated. ( 1.1 ) Locally Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc), As First-Line Treatment In Combination With Carboplatin, In Patients Who Are Not Candidates For Curative Surgery Or Radiation Therapy. ( 1.2 ) Metastatic Adenocarcinoma Of The Pancreas As First-Line Treatment, In Combination With Gemcitabine. ( 1.3 ) 1.1 Metastatic Breast Cancer Abraxane Is Indicated For The Treatment Of Breast Cancer After Failure Of Combination Chemotherapy For Metastatic Disease Or Relapse Within 6 Months Of Adjuvant Chemotherapy. Prior Therapy Should Have Included An Anthracycline Unless Clinically Contraindicated. 1.2 Non-Small Cell Lung Cancer Abraxane Is Indicated For The First-Line Treatment Of Locally Advanced Or Metastatic Non-Small Cell Lung Cancer, In Combination With Carboplatin, In Patients Who Are Not Candidates For Curative Surgery Or Radiation Therapy. 1.3 Adenocarcinoma Of The Pancreas Abraxane Is Indicated For The First-Line Treatment Of Patients With Metastatic Adenocarcinoma Of The Pancreas, In Combination With Gemcitabine.
|